Orap

Orap was FDA approved for treating psychosis and is also used as an antipsychotic. In September 1999, new Orap warnings were issued because of the potentially fatal electrical disturbances of the heart. When Orap was first approved, the treatment option was not supposed to be used in patients that did not first try alternate choices. The Orap warning also stated that combining Orap with other therapies, because of the prolonged QT interval it caused, could have additive effects if the other drugs also prolonged the QT interval.

AL - Alabama

KY - Kentucky

ND - North Dakota

AK - Alaska

LA - Louisiana

OH - Ohio

AZ - Arizona

MA - Massachusetts

OK - Oklahoma

AR - Arkansas

MD - Maryland

OR - Oregon

CA - California

MA - Maine

PA - Pennsylvania

CO - Colorado

MI - Michigan

RI - Rhode Island

CT - Connecticut

MN - Minnesota

SC - South Carolina

DE - Delaware

MS - Mississippi

SD - South Dakota

D.C. - D.C.

MO - Missouri

TN - Tennessee

FL - Florida

MT - Montana

TX - Texas

GA - Georgia

NE - Nebraska

UT - Utah

HI - Hawaii

NV - Nevada

VT - Vermont

ID - Idaho

NH - New Hampshire

VA - Virginia

IL - Illinois

NJ - New Jersey

WA - Washington

IN - Indiana

NM - New Mexico

WV - West Virginia

IA - Iowa

NY - New York

WI - Wisconsin

KS - Kansas

NC - North Carolina

WY - Wyoming